Factory in a Box Launched for Production of Viral Vector–Based Therapeutics

Officials at GE Healthcare say the company is launching a ready-to-run “factory-in-a-box” to accelerate the production of viral vector–based therapeutics, including viral vector–based vaccines, oncolytic viruses, and cell and gene therapies . The new, prefabricated, and modular KUBio biomanufacturing facility is designed, constructed, assembled, and fully fitted-out to current cGMP standards significantly faster that is required to build a traditional, stick-built manufac